Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

1992 Abstracts/Presentations

  1. Parchment, R.E., M. Huang, J.G. Page, B.L. Osborn, J.E. Tomaszewski and M.J. Murphy, Jr., 1992. New Anti-HIV Agents with Favorable Human Myelotoxicity In Vitro. 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam.
  2. Parchment, R.E., M. Huang, J.E. Tomaszewski and M.J. Murphy, Jr., 1992. Murine CFU-GM Assays are Optimized for Preclinical Myelotoxicity Evaluation of New Anti-HIV and Anti-cancer Drugs. 7th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam.
  3. Daniel, E.M., J.T. Liao, T.N. Merriman, D.E. Rodwell, M.G. Wientjes, B.L. Osborn and J.E. Tomaszewski, 1992. Pharmacokinetics and Bioavailability Study of Merck L651582 (NSC-609974) in Beagle Dogs. [Abstract No. 3166]. Proc. Amer. Assoc. Cancer Res., 33, 530.
  4. Dixit, R., R. Lopez, T. Douglas, C. Fanska, M. Stoltz, D. Arneson, M. Stedham, A.C. Smith and J.E. Tomaszewski, 1992. The Intravenous Infusion Toxicity of 9-Amino-20[S]-Camptothecin (9-AC, NSC-603071) in Beagle Dogs. [Abstract No. 3278]. Proc. Amer. Assoc. Cancer Res., 33, 548.
  5. Dixit, R., R. Lopez, T. Douglas, P. Muellner, L. Litle, M. Stoltz, D. Arneson, M. Stedham, A.C. Smith and J.E. Tomaszewski, 1992. Toxicity of a Five-Hour Intravenous Infusion of Penclomedine (PEN, NSC-338720) In Beagle Dogs. [Abstract No. 3279]. Proc. Amer. Assoc. Cancer Res., 33, 548.
  6. Freeman, G.B., M.E. Placke, M.J. Ryan, A.C. Smith and J.E. Tomaszewski, 1992. Repeated-Dose Toxicity Studies of UC38, 1-Methylethl 2-Chloro-5-[[(1- Methylethoxy) Thiomethyl] Amino] Benzoate (NSC-629243) in Beagle Dogs. [Abstract No. 3287]. Proc. Amer. Assoc. Cancer Res., 33, 550. Wilkinson, G.E., M.E. Placke, R.L. Persing, M.J. Ryan, A.C. Smith and J.E. Tomaszewski, 1992. 14- and 28- Day Toxicity Studies of UC38, 1-Methylethyl 2-Chloro-5[[(1-Methylethoxy) Thiomethyl] Amino]Benzoate (NSC-629243) in Hamsters. [Abstract No. 3288]. Proc. Amer. Assoc. Cancer Res., 33, 550.
  7. Osborn, B.L., E.M. Daniel, J.T. Liao, D.E. Rodwell, R.M. Kovatch and J.E. Tomaszewski, 1992. 28 Day Toxicity Studies of Merck L651582 (CAI, NSC-609974) in Rats and Dogs. [Abstract No. 3289]. Proc. Amer. Assoc. Cancer Res., 33, 550.
  8. May, R.D., M.J. Murphy, Jr., R.E. Parchment, M. Huang, B.L. Osborn, J.E. Tomaszewski and J.G. Page, 1992. Toxicity Evaluation of Deveopmental Anticancer/Anti-HIV Compounds to Mouse and Human Bone Marrow Progenitor Cells. [Abstract No. 3291]. Proc. Amer. Assoc. Cancer Res., 33, 550.
  9. Rodman, L.E., H.D. Giles, J.M. Trang, J.E. Heath, L.M. Rose, A.G. Garrett, R.S. Sparks, J.E.Tomaszewski, B.L. Osborn and J.G. Page, 1992. Preclinical Toxicology and Pharmacokinetic Studies of Mitoguazone (NSC-32946), Carbamazepine, and Difluoromethylornithine in Rats. Administered Singly or in Combination. [Abstract No. 3292]. Proc. Amer. Assoc. Cancer Res., 33, 551.
  10. Supko JG, Plowman J, Dykes DJ, Zaharko DS, 1992. Relationship Between the Schedule of 9-Amino-20(S)-camptothecin (AC; NSC 603071) Antitumor Activity in Mice and its Plasma Pharmacokinetics. [Abstract No. 2578]. Proc. Amer. Assoc. Cancer Res., 33, 432.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director, collinsje@mail.nih.gov